FI920630A0 - Transdermalt nitroglycerinplaoster med penetration befraemjande medel. - Google Patents

Transdermalt nitroglycerinplaoster med penetration befraemjande medel.

Info

Publication number
FI920630A0
FI920630A0 FI920630A FI920630A FI920630A0 FI 920630 A0 FI920630 A0 FI 920630A0 FI 920630 A FI920630 A FI 920630A FI 920630 A FI920630 A FI 920630A FI 920630 A0 FI920630 A0 FI 920630A0
Authority
FI
Finland
Prior art keywords
transdermalt
nitroglycerinplaoster
befraemjande
medel
med
Prior art date
Application number
FI920630A
Other languages
English (en)
Inventor
Sharad K Govil
Edward M Rudnic
Dale G Sterner
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI920630A0 publication Critical patent/FI920630A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
FI920630A 1989-08-17 1992-02-14 Transdermalt nitroglycerinplaoster med penetration befraemjande medel. FI920630A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39511989A 1989-08-17 1989-08-17
PCT/US1990/004456 WO1991002553A2 (en) 1989-08-17 1990-08-15 Transdermal nitroglycerin patch with penetration enhancers

Publications (1)

Publication Number Publication Date
FI920630A0 true FI920630A0 (fi) 1992-02-14

Family

ID=23561776

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920630A FI920630A0 (fi) 1989-08-17 1992-02-14 Transdermalt nitroglycerinplaoster med penetration befraemjande medel.

Country Status (11)

Country Link
EP (2) EP0486529A1 (fi)
AU (1) AU643230B2 (fi)
CA (1) CA2064845A1 (fi)
FI (1) FI920630A0 (fi)
HU (1) HUT59596A (fi)
IE (1) IE902970A1 (fi)
IL (1) IL95387A0 (fi)
NZ (1) NZ234919A (fi)
PT (1) PT95012A (fi)
WO (1) WO1991002553A2 (fi)
ZA (1) ZA906472B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
JP5820206B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820207B2 (ja) * 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US20220193001A1 (en) * 2020-12-23 2022-06-23 GameChanger Patch Co. Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
EP0224981A3 (en) * 1985-11-04 1988-08-10 Paco Research Corporation Nitroglycerin transdermal delivery system
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
JPH069007B2 (ja) * 1986-04-04 1994-02-02 フアナツク株式会社 複合曲面のｎｃデ−タ作成方法
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
JPS63170316A (ja) * 1986-12-30 1988-07-14 Fujimoto Seiyaku Kk ニフエジピン経皮吸収外用製剤
EP0290262A3 (en) * 1987-05-08 1990-12-12 EASTMAN KODAK COMPANY (a New Jersey corporation) Improved nitrate therapy for angina pectoris
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems

Also Published As

Publication number Publication date
EP0417496A2 (en) 1991-03-20
ZA906472B (en) 1991-05-29
EP0486529A1 (en) 1992-05-27
WO1991002553A3 (en) 1991-04-04
PT95012A (pt) 1991-05-22
HUT59596A (en) 1992-06-29
NZ234919A (en) 1992-07-28
IE902970A1 (en) 1991-02-27
EP0417496A3 (en) 1991-07-03
HU9200459D0 (en) 1992-05-28
WO1991002553A2 (en) 1991-03-07
CA2064845A1 (en) 1991-02-18
IL95387A0 (en) 1991-06-30
AU6141090A (en) 1991-04-03
AU643230B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
FI901243A0 (fi) Antiperspirantcremer med laog aoterstod.
FI875363A (fi) O-substituerade tetrahydropyridinoximer saosom kolinergiska medel.
FI901356A0 (fi) Med luktkontrollmaterial foersedda absorberande strukturer.
DE69006406D1 (de) Brennerstein-Aufbau.
FI901321A0 (fi) Med bindemedel oeverdragen kapillaer transportzon.
DE69021088T2 (de) Bodenvernagelung.
FI900741A0 (fi) Med ultraviolett straolning haerdbart epoxisilikon-/polyolsystem.
FI900577A0 (fi) 1-bentzyl-3-hydroximetyl-indazoletrar med alifatiska 2-hydroxisyror.
FI900237A0 (fi) Agglomerat med laog taethet.
FI900859A0 (fi) Aminohartsloesningar med liten elektrisk ledningsfoermaoga.
FI895186A0 (fi) Dubbeldiffusoer med aoterspolningskolvar.
FI900489A0 (fi) Kontnaerers sektional spaennram med en kanfas.
FI920630A0 (fi) Transdermalt nitroglycerinplaoster med penetration befraemjande medel.
FI874164A (fi) Behandlade lipidreglerande medel.
FI900871A0 (fi) Patoeriseringsbestaendigt medel foer eliminering av syre.
FI894037A (fi) Kraftnormal-maetanordning med hydraulisk kraftomsaettning.
FI896058A0 (fi) Flercylindrig foerbraenningsmotor med skilda cylindertoppar.
FI882332A0 (fi) Antiarrytmiska medel.
FI884561A0 (fi) Temperaturangivare foer aotnjutbara medel.
FI892304A0 (fi) Medel foer foerhindrande av tillfrysning av en brandpost.
ES1012347Y (es) Mondadientes mejorado.
FI895429A0 (fi) Med reducerad tryckaonga fungerande vaermebehandlingsanordning.
FI891942A0 (fi) Med luftkuddar foersedd saeng.
FI895629A (fi) Energibesparande elektrostatisk gasrenare med inversionsdrift.
FI890333A (fi) Oever-/undertryckssaekerhetsventil foersedd med en motvikt.

Legal Events

Date Code Title Description
FD Application lapsed